Glutamine as a component of nutritional and metabolic therapy for surgical patients in ICU

Dmitriev A.V.; Machulina I.A.; Shestopalov A.E.

doi:https://doi.org/10.17116/hirurgia202108198

Close metadata

Recommended articles:

Transfusion therapy of the XIX century — the beginning of the formation of parenteral nutrition for surgical patients. Pirogov Russian Journal of Surgery. 2025;(3):156-163

Efficacy and safety of Russian-made peripherally inserted central catheters in premature infants: a randomized clinical trial. Russian Journal of Anesthesiology and Reanimatology. 2025;(6):58-67

Gastrointestinal failure in postoperative period. Russian Journal of Anesthesiology and Reanimatology. 2025;(6):107-117

Abstract:

Glutamine is the most abundant amino acid in the human body that is involved in various metabolic processes. The development of hypermetabolic and hypercatabolic syndrome that accompanies critical conditions of ICU patients is associated with a decrease in the concentration of glutamine, especially in the blood plasma and muscles. This process may last for quite a long time and lead to a number of complications up to a fatal outcome. This review was aimed to analyze clinical studies conducted over the past 20 years that demonstrate the effect of intravenous infusion of glutamine dipeptide as part of balanced parenteral nutrition on the perioperative period: the severity of inflammatory response; the state of the intestinal mucosa; the incidence and severity of complications; mortality; the duration of stay in the ICU and hospital in general, etc. The analysis was performed using systematic reviews and meta-analyses based on randomized double-blind, placebo-controlled trials in different countries selected in the main databases (PubMed, EMBASE, Web of Science, The Cochrane Library, etc.). Most of the reports state that the inclusion of glutamine dipeptide in nutritional and metabolic therapy (NMT) in surgical patients reduces the frequency and severity of infectious complications and mortality, reduces the length of stay in ICU and in hospital in general, improves the biochemical parameters that reflect the condition of patients, and reduces the treatment costs. Thus, the conducted systematic reviews and meta-analyses confirm that the use of the parenteral form of glutamine dipeptide (Dipeptiven 20%) as part of balanced standard parenteral nutrition (PN) is a clinically and pharmacoeconomically justified strategy of NMT in surgical ICU patients.

Keywords:

surgical ICU patients

hypermetabolic and hypercatabolic syndrome

parenteral nutrition

glutamine

Authors:

Dmitriev A.V.

SBHI City Clinical Hospital No. 70 named after E.O. Mukhin of the Moscow City

ORCID: 0000-0001-6975-6103

Machulina I.A.

SBHI City Clinical Hospital No. 70 named after E.O. Mukhin of the Moscow City Health Department, Mosco

ORCID: 0000-0002-9466-7556

Shestopalov A.E.

N.N. Burdenko Main Military Clinical Hospital of the Ministry of Defense of Russia;
Northwest Society for Parenteral and Enteral Nutrition

Scopus AuthorID: 8295880000
ORCID: 0000-0002-5278-7058

Received:

25.05.2021

Accepted:

15.06.2021

Close metadata

References:

Zheng Y-M, Li F, Zhang M-M, Wu YT. Glutamine dipeptide for parenteral nutrition in abdominal surgery: A meta-analysis of randomized controlled trials. World J Gastroenterol. 2006;12(46):7537-7541. https://doi.org/10.3748/wjg.v12.i46.7537
Bertolini G, Boffelli S, Malacarne P, Peta M, Marchesi M, Barbisan C, Tomelleri S, Spada S, Satolli R, Gridelli B, Lizzola I, Mazzon D. End-of-life decision-making and quality of ICU performance: an observational study in 84 Italian units. Intens Care Med. 2010;36(9):1495-1504. https://doi.org/10.1007/s00134-010-1910-9
Tarricone R, Torbica A, Franzetti F, Rosenthal VD. Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed vs open infusion containers. The case of intensive care units in Italy. Cost Eff Resour Alloc. 2010;8:8. https://doi.org/10.1186/1478-7547-8-8
Oudemans-van Straaten HM, Bosman RJ, Treskes M, Van der Spoel HJ, Zandstra DF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intens Care Med. 2001;27(1):84-90. https://doi.org/10.1007/s001340000703
Wernerman J, Kirketeig T, Andersson B, Berthelson H, Ersson A, Friberg H, Guttormsen AB, Hendrikx S, Pettila V, Rossi P, Sjoberg F, Winso O. Scandinavian glutamine trial: a pragmatic multi-centre randomized clinical trial of intensive care unit patients. Acta Anaesthesiol Scand. 2011;55(7):812-818. https://doi.org/10.1111/j.1399-6576.2011.02453.x
Bollhalder L, Pfeil AM, Tomonaga Y, Schwenkglenks M. A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clin Nutr. 2012;32(2):213-223. https://doi.org/10.1016/j.clnu.2012.11.003
Zhong X, Liang CP, Gong S. Intravenous glutamine for sever acute pancreatitis: a meta-analysis. World J Crit Care Med. 2013;2(1):4-8. https://doi.org/10.5492/wjccm.v2.i1.4
Wischmeyer PE, Dhaliwal R, McCall M, Ziegler TR, Heyland DK. Parenteral glutamine supplementation in critical illness: a systematic review. Crit Care. 2014;18(2):R76. https://doi.org/10.1186/cc13836
Shu X-L, Yu T-T, Kang K, Zhao J. Effects of glutamine on markers of intestinal inflammatory response and mucosal permeability in abdominal surgery patients: A meta-analysis. Exp Ther Med. 2016;12(6):3499-3506. https://doi.org/10.3892/etm.2016.3799
Stehle P, Ellger B, Kojic D, Feuersenger A, Schneid C, Stover J, Scheiner D, Westphal M. Glutamine dipeptide-supplemented parenteral nutrition improves the clinical outcomes of critically ill patients: a systematic evaluation of randomized controlled trials. Clin Nutr. ESPEN. 2017;17:75-85. https://doi.org/10.1016/j.clnesp.2016.09.007
Pimentel RFW, Fernandes SL. Effects of parenteral glutamine in critically ill surgical patients: a systematic review and meta-analysis. Nutr Hosp. 2020;37(3):616-621. https://doi.org/10.20960/nh.02949
Mertes N, Schulzki C, Goeters C, Winde G, Benzing S, Kuhn KS, Van Aken H, Stehle P, Furst P. Cost containment through L-alanyl-L-glutamine supplemented total PN after major abdominal surgery: a prospective randomized double-blind controlled study. Clin Nutr. 2000;19(5):395-401. https://doi.org/10.1054/clnu.2000.0142
Ziegler TR, Bazargan N, Galloway JR. Glutamine supplemented nutrition support: saving nitrogen and saving money? Clin Nutr. 2000;19(6):375-377. https://doi.org/10.1054/clnu.2000.0360
Spittler A, Sautner T, Gornikiewicz A, Manhart N, Oehler R, Bergmann M, Fugger R, Roth E. Postoperative glycyl-glutamine infusion reduces immunosuppression: partial prevention of the surgery induced decrease in HLA-DR expression on monocytes. Clin Nutr. 2001;20(1):37-42. https://doi.org/10.1054/clnu.2000.0153
Exner R, Tamandl D, Goetzinger P, Mittboeck M, Fuegger R, Sautner T, Spittler A, Roth E. Perioperative GLY-GLN infusion diminishes the surgery-induced period of immunosuppression: accelerated restoration of the lipopolysaccharide-stimulated tumor necrosis factor-alpha response. Ann Surg. 2003;237(1):110-115. https://doi.org/10.1097/00000658-200301000-00015
Fuentes-Orozco C, Anaya-Prado R, González-Ojeda A, Arenas-Márquez H, Cabrera-Pivaral C, Cervantes-Guevara G, Barrera-Zepeda LM. L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr. 2004;23(1):13-21. https://doi.org/10.1016/s0261-5614(03)00055-4
Estívariz CF, Griffith DP, Luo M, Szeszycki EE, Bazargan N, Dave N, Daignault NM, Bergman GF, McNally T, Battey CH, Furr CE, Hao L, Ramsay JG, Accardi CR, Cotsonis GA, Jones DP, Galloway JR, Ziegler TR. Efficacy of Parenteral Nutrition Supplemented With Glutamine Dipeptide to Decrease Hospital Infections in Critically Ill Surgical Patients. J Parenter Enteral Nutr. 2008;32(4):389-402. https://doi.org/10.1177/0148607108317880
Orfila GM, Talaverón JL. Effectiveness of perioperative glutamine in parenteral nutrition in patients at risk of moderate to severe malnutrition. Nutr Hosp. 2011;26(6):1305-1312. https://doi.org/10.1590/s0212-16112011000600017
Rosenthal MD, Vanzant EL, Martindale RG, Moore FA. Evolving paradigms in the nutritional support of critically ill surgical patients. Curr Probl Surg. 2015;52(4):147-182. https://doi.org/10.1067/j.cpsurg.2015.02.003
Coëffier M, Déchelotte P. The Role of Glutamine in Intensive Care Unit Patients: Mechanisms of Action and Clinical Outcome. Nutr Rev. 2005;63(2):65-69. https://doi.org/10.1111/j.1753-4887.2005.tb00123.x
Lin M, Kung SP, Yeh SL, Liaw KY, Wang MY, Kuo ML, Lee PH, Chen WJ. Glutamine-supplemented total parenteral nutrition attenuates plasma interleukin-6 in surgical patients with lower disease severity. World J Gastroenterol. 2005;11(39):6197-6201. https://doi.org/10.3748/wjg.v11.i39.6197
De-Souza DA, Greene LJ. Intestinal permeability and systemic infections in critically ill patients: Effect of glutamine. Crit Care Med. 2005;33(5):1125-1135. https://doi.org/10.1097/01.ccm.0000162680.52397.97
Wischmeyer PE. Glutamine: role in critical illness and ongoing clinical trials. Curr Opin Gastroenterol. 2008;24(2):190-197. https://doi.org/10.1097/mog.0b013e3282f4db94
Looft VM, Dmitriev AV. The Metabolic Optimized Fast Track Concept: preoperative preparation for abdominal surgery. Pirogov Russian Journal of Surgery. 2017;10:65-71. (In Russ.). https://doi.org/10.17116/hirurgia20171065-71
Roth E. Immune and cell modulation by amino acids. Clin Nutr. 2007;26(5):535-544. https://doi.org/10.1016/j.clnu.2007.05.007
Roth E. Nonnutritive Effects of Glutamine. J Nutr. 2008;138(10):2025-2031. https://doi.org/10.1093/jn/138.10.2025s
Pradelli L, Iannazzo S, Zaniolo O, Muscaritoli M, Eandi M. Effectiveness and cost-effectiveness of supplemental glutamine dipeptide in total PN therapy for critically ill patients: a discrete event simulation model based on Italian data. Int J Technol Assess Health Care. 2012;28(1):22-28. https://doi.org/10.1017/s0266462311000705
Pradelli L, Povero M, Muscaritoli M, Eandi M. Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients. Eur J Clin Nutr. 2015;69(5):546-551. https://doi.org/10.1038/ejcn.2014.255
Zhou Y-P, Jiang Z-M, Sun Y-H, Wang XR, Ma EL, Wilmore D. The effects of supplemental glutamine dipeptide on gut integrity and clinical outcome after major escharectomy in severe burns: a randomized, double-blind, controlled clinical trial. Clin Nutr Suppl. 2004;1(1):55-60. https://doi.org/10.1016/j.clnu.2004.07.012
Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med. 2002;30(9):2022-2029. https://doi.org/10.1097/00003246-200209000-00011
Wang Y, Jiang Z-M, Nolan MT, Jiang H, Han HR, Yu K, Li H.L, Jie B, Liang XK. The impact of glutamine dipeptide-supplemented parenteral nutrition on outcomes of surgical patients: a meta-analysis of randomized clinical trials. J Parenter Enteral Nutr. 2010;34(5):521-529. https://doi.org/10.1177/0148607110362587
Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, Hiesmayr M, Mayer K, Montejo JC, Pichard C, Preiser JC, Van Zanten ARH, Oczkowski S, Szczeklik W, Bischoff SC. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38(1):48-79. https://doi.org/10.1016/j.clnu.2018.08.037
Furst P, Albers S, Stehle P. Evidence for a nutritional need for glutamine in catabolic patients. Kidney Int Suppl. 1989;27:287-292.
Rodas PC, Rooyackers O, Hebert C, Norberg C, Wernerman J. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci. 2012;122(12):591-597. https://doi.org/10.1042/cs20110520
Wernerman J. Glutamine supplementation to critically ill patients. Crit Care. 2014;18(2):214. https://doi.org/10.1186/cc13781
Blass SC, Goost H, Tolba RH, Stoffel-Wagner B, Kabir K, Burger C, Stehle P, Ellinger S. Time to wound closure in trauma patients with disorders in wound healing is shortened by supplements containing antioxidant micronutrients and glutamine: a PRCT. Clin Nutr. 2012;31(4):469-475. https://doi.org/10.1016/j.clnu.2012.01.002
Lin JJ, Chung XJ, Yang CY, Lau HL. A meta-analysis of trials using the intention to treat principle for glutamine supplementation in critically ill patients with burn. Burns. 2013;39(4):565-570. https://doi.org/10.1016/j.burns.2012.11.008
Van Zanten AR, Dhaliwal R, Garrel D, Heyland DK. Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis. Crit Care. 2015;19(1):294. https://doi.org/10.1186/s13054-015-1002-x
Rousseau AF, Losser MR, Ichai C, Berger MM. ESPEN endorsed recommendations: nutritional therapy in major burns. Clin Nutr. 2013;32(4):497-502. https://doi.org/10.1016/j.clnu.2013.02.012
Kibor DK, Nyaim OE, Wanjeri K. Effects of enteral glutamine supplementation on reduction of infection in adult patients with severe burns. East Afr Med J. 2014;91(1):33-36.
Лейдерман И.Н., Грицан А.И., Заболотских И.Б., Ломидзе С.В., Мазурок В.А., Нехаев И.В., Николаенко Э.М., Николенко А.В., Поляков И.В., Сытов А.В., Ярошецкий А.И. Периоперационная нутритивная поддержка. Клинические рекомендации. Общероссийская общественная организация «Федерация анестезиологов и реаниматологов». Рекомендация 14. «Показания к внутривенному введению растворов глутамина». Вестник интенсивной терапии им. А.И. Салтанова. 2018;3:13-14.
Leyderman IN, Gritsan AI, Zabolotskikh IB, Lomidze SV, Mazurok VA, Nekhaev IV, Nikolaenko EM, Nikolenko AV, Poliakov IV, Sytov AV, Yaroshetskiy AI. Perioperative nutritional support. Russian Federation of anesthesiologists and reanimatologists guidelines. Recommendation 14. «Indications for intravenous administration of glutamine solutions». Intensive care bulletin A.I. Saltanov. 2018;3:13-14. (In Russ.).